CHINARES PHARMA Declares HKD 0.139 Final Dividend for FY 2025; Ex-Dividend Date 17 June 2026

Bulletin Express05-19

China Resources Pharmaceutical Group Limited (CHINARES PHARMA) has announced a final ordinary dividend of RMB 0.122 (HKD 0.139) per share for the financial year ended 31 December 2025. The dividend will be paid on 03 August 2026, subject to shareholder approval on 12 June 2026.

The distribution offers a currency option. Shareholders may elect to receive the dividend in RMB at RMB 0.122 per share or in HKD at HKD 0.139 per share, based on the fixed exchange rate of RMB 1 : HKD 1.1363. Partial currency elections are permitted, and the election window closes at 16:30 on 16 July 2026.

Key timetable: • Ex-dividend date: 17 June 2026 • Last day to lodge share transfers: 18 June 2026 (16:30) • Book-closure period: 22–23 June 2026 • Record date: 23 June 2026

Tricor Investor Services Limited will act as share registrar, with its office at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.

The announcement specifies no withholding tax on the dividend and notes no outstanding listed warrants or convertible securities. As of the announcement date, the board is chaired by Mr. Bai Xiaosong and comprises 12 directors, including executive, non-executive and independent non-executive members.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1100775620?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-19 06:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1100775620","market":"hk","top_or_hot":-1,"title":"CHINARES PHARMA Declares HKD 0.139 Final Dividend for FY 2025; Ex-Dividend Date 17 June 2026","media":"Bulletin Express","content":"<p>China Resources Pharmaceutical Group Limited (CHINARES PHARMA) has announced a final ordinary dividend of RMB 0.122 (HKD 0.139) per share for the financial year ended 31 December 2025. The dividend will be paid on 03 August 2026, subject to shareholder approval on 12 June 2026.</p>\n<p>The distribution offers a currency option. Shareholders may elect to receive the dividend in RMB at RMB 0.122 per share or in HKD at HKD 0.139 per share, based on the fixed exchange rate of RMB 1 : HKD 1.1363. Partial currency elections are permitted, and the election window closes at 16:30 on 16 July 2026.</p>\n<p>Key timetable:\n• Ex-dividend date: 17 June 2026  \n• Last day to lodge share transfers: 18 June 2026 (16:30)  \n• Book-closure period: 22–23 June 2026  \n• Record date: 23 June 2026</p>\n<p>Tricor Investor Services Limited will act as share registrar, with its office at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.</p>\n<p>The announcement specifies no withholding tax on the dividend and notes no outstanding listed warrants or convertible securities. As of the announcement date, the board is chaired by Mr. Bai Xiaosong and comprises 12 directors, including executive, non-executive and independent non-executive members.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CHINARES PHARMA Declares HKD 0.139 Final Dividend for FY 2025; Ex-Dividend Date 17 June 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCHINARES PHARMA Declares HKD 0.139 Final Dividend for FY 2025; Ex-Dividend Date 17 June 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-19 06:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>China Resources Pharmaceutical Group Limited (CHINARES PHARMA) has announced a final ordinary dividend of RMB 0.122 (HKD 0.139) per share for the financial year ended 31 December 2025. The dividend will be paid on 03 August 2026, subject to shareholder approval on 12 June 2026.</p>\n<p>The distribution offers a currency option. Shareholders may elect to receive the dividend in RMB at RMB 0.122 per share or in HKD at HKD 0.139 per share, based on the fixed exchange rate of RMB 1 : HKD 1.1363. Partial currency elections are permitted, and the election window closes at 16:30 on 16 July 2026.</p>\n<p>Key timetable:\n• Ex-dividend date: 17 June 2026  \n• Last day to lodge share transfers: 18 June 2026 (16:30)  \n• Book-closure period: 22–23 June 2026  \n• Record date: 23 June 2026</p>\n<p>Tricor Investor Services Limited will act as share registrar, with its office at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.</p>\n<p>The announcement specifies no withholding tax on the dividend and notes no outstanding listed warrants or convertible securities. As of the announcement date, the board is chaired by Mr. Bai Xiaosong and comprises 12 directors, including executive, non-executive and independent non-executive members.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03320","symbol_name":"华润医药","start_time":0,"source_url":"","article_id":"1100775620","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1100775620","pubTimestamp":1779144203,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"China Resources Pharmaceutical Group Limited (CHINARES PHARMA) has announced a final ordinary dividend of RMB 0.122 (HKD 0.139) per share for the financial year ended 31 December 2025. The dividend...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03320":"华润医药"},"translate_title":"CHINARES PHARMA宣布派发2025财年末期股息0.139港元；除息日2026年6月17日","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03320":1},"content_text":"China Resources Pharmaceutical Group Limited (CHINARES PHARMA) has announced a final ordinary dividend of RMB 0.122 (HKD 0.139) per share for the financial year ended 31 December 2025. The dividend will be paid on 03 August 2026, subject to shareholder approval on 12 June 2026.\nThe distribution offers a currency option. Shareholders may elect to receive the dividend in RMB at RMB 0.122 per share or in HKD at HKD 0.139 per share, based on the fixed exchange rate of RMB 1 : HKD 1.1363. Partial currency elections are permitted, and the election window closes at 16:30 on 16 July 2026.\nKey timetable:\n• Ex-dividend date: 17 June 2026  \n• Last day to lodge share transfers: 18 June 2026 (16:30)  \n• Book-closure period: 22–23 June 2026  \n• Record date: 23 June 2026\nTricor Investor Services Limited will act as share registrar, with its office at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.\nThe announcement specifies no withholding tax on the dividend and notes no outstanding listed warrants or convertible securities. As of the announcement date, the board is chaired by Mr. Bai Xiaosong and comprises 12 directors, including executive, non-executive and independent non-executive members.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1100775620","isCrawlerRequest":true}